Why is it so much harder to develop an HIV/AIDS vaccine than a COVID-19 vaccine?
There are unique difficulties facing the development of an effective vaccine against HIV/AIDS. Image: REUTERS/Hannah McKay
Ronald C. Desrosiers
Professor of Pathology, Vice-chair for Research, University of Miami
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
Vaccination
What is the World Economic Forum doing about access to vaccines?
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Related topics:
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
Subscribe
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
